Close

Intercept Pharma's (ICPT) OCA Receives Breakthrough Therapy Designation in NASH

January 29, 2015 4:08 PM EST Send to a Friend
Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (Intercept), today announced that its investigational product obeticholic acid (OCA) has received "breakthrough therapy designation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login